Multiple Sclerosis Centers of Excellence
Interferon Beta-1a (Avonex®)
Interferon beta-1a (Avonex®) is a medication administered by weekly IM injections for the treatment of relapsing forms of MS. Interferon beta-1a is theorized to down-regulate proinflammatory cytokines, decrease major histocompatibility antigens and reduce T-lymphocyte passage across the blood brain barrier.
For Additional Information
- Interferon Beta-1a (Avonex®) Prescribing Information for Healthcare Professionals
- Interferon Beta-1a (Avonex®) Medication Guide for Patients
- Avonex® (website for patients and healthcare professionals)